Regulator links Sanofi epilepsy drug to child deformities

An estimated 2,150 to 4,100 children in France suffered a major malformation in the womb between 1967 and 2016 after their mothers took a treatment against epilepsy and bipolar disorders known as valproate, France’s drug regulator said on Thursday.

Valproate, which has been manufactured in France by Sanofi under the brand Depakine in the field of epilepsy and Depakote and Depamide in bipolar disorders, is also believed to cause slow neurological development.

ANSM, France’s drug authority, said it would also publish a study on neurological effects in the second half of 2017.

Sanofi was not immediately available for comment.

Valproate was approved as an anti-epileptic drug in France in 1967 and has become one of the most widely prescribed treatments for the condition worldwide.

Parents of those affected say the French state and Sanofi were too slow to warn of the side effects of the drug, after the risks to fetuses became clear by the early 1980s.

(Reporting by Matthias Blamont, Editing by Sarah White)

Read More at Reuters

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

5 Healthy Ways This Fitness Star Is Prepping for Her Wedding
4 Healthy Reasons to Eat Avocados
The Salad Trend You Didn’t Know You Needed
Got 30 Minutes? The Ultimate HIIT Jump Rope Workout
5 Healthy Ways This Fitness Star Is Prepping for Her Wedding
4 Ideas for Using Herbs You Probably Haven’t Thought Of
Bobbi Brown’s Top 10 Superfoods for Beauty and the Fun Way She Eats Them
Lena Dunham’s Trainer Tracy Anderson Says She Wanted to ‘Feel Better’ and Not Make Her Body ‘Look Different’
The Easy Frozen Yogurt Dessert You’ll Be Eating All Summer Long
A Food-Lover’s Mother’s Day Gift Guide
4 Foolproof Tips to Make Healthy Veggie Chips at Home
4 Healthy Reasons to Eat Avocados
No Preview
WHO says India reports cases of Zika virus
Two Scientists, Two Different Approaches To Saving Bees From Poison Dust
How A Gene Editing Tool Went From Labs To A Middle-School Classroom
Sensory and diet therapies for autism lack strong evidence